...
首页> 外文期刊>Head and neck: Journal for the sciences and specialities of the head and neck >Results of 226 patients with T3 laryngeal carcinoma after treatment with transoral laser microsurgery
【24h】

Results of 226 patients with T3 laryngeal carcinoma after treatment with transoral laser microsurgery

机译:经口腔激光显微手术治疗的226例T3喉癌患者的结果

获取原文
获取原文并翻译 | 示例
           

摘要

Background The purpose of this study was to assess the feasibility of transoral laser microsurgery (TLM) in treatment of pT3 laryngeal cancer. Methods We conducted a retrospective case series study of 226 patients with pT3 glottic (n = 122; 54%) or supraglottic laryngeal carcinoma (n = 104; 46%). All patients were treated by TLM in combination with neck dissection (63%) and with postoperative radiotherapy (18%). Our main outcome measures were local control, organ preservation, functional outcome, overall survival, recurrence-free survival, and disease-specific survival. Results Median follow-up period was 57.8 months. The 5-year organ-preservation and local control rates for all patients were 87% and 71.4%, respectively. The 5-year overall, recurrence-free, and disease-specific survival were 64.4%, 63.0%, and 83.3%, respectively. Conclusion Results are comparable to partial or total laryngectomy, while being superior to primary chemo(radio)therapy. TLM results in low morbidity, rapid recovery, and good function and can be a valid option for organ-preserving surgery of pT3 glottic and supraglottic cancer.
机译:背景技术这项研究的目的是评估经口激光显微外科手术(TLM)在治疗pT3喉癌中的可行性。方法我们对226例pT3声门癌(n = 122; 54%)或声门上喉癌(n = 104; 46%)患者进行了回顾性病例系列研究。所有患者均接受TLM联合颈淋巴清扫术(63%)和术后放疗(18%)的治疗。我们的主要预后指标是局部控制,器官保存,功能预后,总生存期,无复发生存期和疾病特异性生存期。结果中位随访时间为57.8个月。所有患者的5年器官保存率和局部控制率分别为87%和71.4%。 5年总生存率,无复发生存率和疾病特异性生存率分别为64.4%,63.0%和83.3%。结论结果与部分或全部喉切除术相当,同时优于主要的化学(放射)治疗。 TLM导致发病率低,恢复快且功能良好,并且可能是pT3声门和声门上癌的器官保留手术的有效选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号